CT versus FDG-PET/CT response evaluation in patients with metastatic colorectal cancer treated with irinotecan and cetuximab

18-FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY AS A TOOL FOR RESPONSE PREDICTION IN SOLID TUMOURS

(2014) D. J. De Maeseneer et al.   ACTA CLINICA BELGICA

Comparison of EORTC Criteria and PERCIST for PET/CT Response Evaluation of Patients with Metastatic Colorectal Cancer Treated with Irinotecan and Cetuximab

(2013) K. Skougaard et al.   JOURNAL OF NUCLEAR MEDICINE

Bevacizumab in combination with cetuximab and irinotecan after failure of cetuximab and irinotecan in patients with metastatic colorectal cancer

(2011) Finn Ole Larsen et al.   ACTA ONCOLOGICA

EGFR related mutational status and association to clinical outcome of third-line cetuximab-irinotecan in metastatic colorectal cancer

(2011) Karen-Lise G Spindler et al.   BMC CANCER

18F-FDG PET/CT for Monitoring Treatment Responses to the Epidermal Growth Factor Receptor Inhibitor Erlotinib

(2011) M. R. Benz et al.   JOURNAL OF NUCLEAR MEDICINE

Implementing prognostic and predictive biomarkers in CRC clinical trials

(2011) Sandra Van Schaeybroeck et al.   Nature Reviews Clinical Oncology

Novel Oncologic Drugs: What They Do and How They Affect Images

(2011) Roberto García Figueiras et al.   RADIOGRAPHICS

The Role of Functional Imaging in Colorectal Cancer

(2010) Roberto Garcia Figueiras et al.   AMERICAN JOURNAL OF ROENTGENOLOGY

Combined Positron Emission Tomography/Computed Tomography in Sunitinib Therapy Assessment of Patients with Metastatic Renal Cell Carcinoma

(2010) M.E. Revheim et al.   CLINICAL ONCOLOGY

Molecular imaging in cancer treatment

(2010) Mark H. Michalski et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Beyond RECIST: Molecular and functional imaging techniques for evaluation of response to targeted therapy

(2009) I.M.E. Desar et al.   CANCER TREATMENT REVIEWS

Monitoring Predominantly Cytostatic Treatment Response with 18F-FDG PET

(2009) K. B. Contractor et al.   JOURNAL OF NUCLEAR MEDICINE

Monitoring and Predicting Response to Therapy with 18F-FDG PET in Colorectal Cancer: A Systematic Review

(2009) L.-F. de Geus-Oei et al.   JOURNAL OF NUCLEAR MEDICINE

Assessing Tumor Response to Therapy

(2009) W. A. Weber   JOURNAL OF NUCLEAR MEDICINE

From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors

(2009) R. L. Wahl et al.   JOURNAL OF NUCLEAR MEDICINE

Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer

(2009) Eric Van Cutsem et al.   NEW ENGLAND JOURNAL OF MEDICINE

Evaluation of different normalization procedures for the calculation of the standardized uptake value in therapy response monitoring studies

(2009) Dennis Vriens et al.   NUCLEAR MEDICINE COMMUNICATIONS

Measuring Response with FDG-PET: Methodological Aspects

(2009) M. Allen-Auerbach et al.   ONCOLOGIST

Targeted KRAS Mutation Assessment on Patient Tumor Histologic Material in Real Time Diagnostics

(2009) Vassiliki Kotoula et al.   PLoS One

Monitoring Response to Therapeutic Interventions in Patients With Cancer

(2009) Ken Herrmann et al.   SEMINARS IN NUCLEAR MEDICINE

Established, emerging and future roles of PET/CT in the management of colorectal cancer

(2008) R.A. Herbertson et al.   CLINICAL RADIOLOGY

K-rasMutations and Benefit from Cetuximab in Advanced Colorectal Cancer

(2008) Christos S. Karapetis et al.   NEW ENGLAND JOURNAL OF MEDICINE

The Lessons of GIST--PET and PET/CT: A New Paradigm for Imaging

(2008) A. D. Van den Abbeele   ONCOLOGIST

DxS Ltd

(2008) Joanne Cross   PHARMACOGENOMICS

Radiologic Measurements of Tumor Response to Treatment: Practical Approaches and Limitations

(2008) Chikako Suzuki et al.   RADIOGRAPHICS

Chemotherapy response evaluation with FDG-PET in patients with colorectal cancer

(2007) L.F. de Geus-Oei et al.   ANNALS OF ONCOLOGY